Concerns mount that Belarus could be a launchpad for a new Russian offensive in Ukraine

New Delhi, June 1 -- Over four years ago, Belarus' authoritarian President Alexander Lukashenko allowed longtime ally Russia to use his territory to invade Ukraine. Now officials in Kyiv are warning t... Read More

मार्च तिमाही में हुआ कंपनी को घाटा, फिर भी आज क्यों 5% चढ़ा शेयर

नई दिल्ली, जून 1 -- इंडिगो की पैरेंट कंपनी इंटरग्लोब एविएशन लिमिटेड (InterGlobe Aviation Ltd) के शेयरों में तेजी देखने को मिली है। तिमाही नतीजों और ब्रोकरेज हाउस की नई रिपोर्ट के बाद कंपनी के शेयरों म... Read More

सरयू के पानी में डूब गई किसानों की उम्मीद, एक हजार एकड़ फसल डूबी

देवरिया, जून 1 -- बरहज(देवरिया), हिन्दुस्तान टीम। असमय सरयू का जलस्तर अचानक बढ़ने से उन किसानों की उम्मीदों पर तुषारापात हो गया है, जिन्होंने बेहतर भविष्य की उम्मीद में रेता क्षेत्र मे मौसमी फल व सब्ज... Read More

ऋषिकेश में स्कूल की छुट्टी पड़ने से यात्रियों का दबाव बढ़ा

देहरादून, जून 1 -- ऋषिकेश। स्कूलों में छुट्टियां पड़ने के बाद यात्रियों का दबाव बढ़ गया है। सोमवार को शहर के विभिन्न तिराहा चौराहा पर पहाड़ जाने वाले यात्रियों की भीड़ रही। भीड़ के चलते लोकल रूटो पर च... Read More

Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, June 1 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Soluti... Read More

Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, June 1 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Mo... Read More

Singapore Clinical Trial: A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors, including Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors

Singapore, June 1 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension (PALM-PAH)

Singapore, June 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evalu... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

Singapore, June 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

Singapore, June 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More

• ««
• «
• 97468
• 97469
• 97470
• 97471
• 97472
• 97473
• 97474
• 97475
• 97476
• 97477
• »
• »»